DRW Securities LLC reduced its position in shares of UnitedHealth Group Incorporated (NYSE:UNH – Free Report) by 67.0% in the 3rd quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission (SEC). The firm owned 1,031 shares of the healthcare conglomerate’s stock after selling 2,094 shares during the period. DRW Securities LLC’s holdings in UnitedHealth Group were worth $602,000 at the end of the most recent quarter.
Other hedge funds and other institutional investors have also bought and sold shares of the company. Kathleen S. Wright Associates Inc. bought a new position in shares of UnitedHealth Group in the 3rd quarter valued at about $27,000. Macroview Investment Management LLC raised its stake in shares of UnitedHealth Group by 671.4% during the 2nd quarter. Macroview Investment Management LLC now owns 54 shares of the healthcare conglomerate’s stock worth $28,000 after purchasing an additional 47 shares in the last quarter. Bbjs Financial Advisors LLC bought a new position in shares of UnitedHealth Group in the second quarter valued at $31,000. Global Wealth Strategies & Associates raised its position in UnitedHealth Group by 152.4% during the third quarter. Global Wealth Strategies & Associates now owns 53 shares of the healthcare conglomerate’s stock worth $31,000 after acquiring an additional 32 shares in the last quarter. Finally, Signature Resources Capital Management LLC grew its position in shares of UnitedHealth Group by 40.0% in the 2nd quarter. Signature Resources Capital Management LLC now owns 63 shares of the healthcare conglomerate’s stock valued at $32,000 after acquiring an additional 18 shares during the period. Institutional investors and hedge funds own 87.86% of the company’s stock.
Analyst Ratings Changes
A number of equities analysts recently commented on UNH shares. Hsbc Global Res cut UnitedHealth Group from a “strong-buy” rating to a “hold” rating in a report on Thursday, October 17th. TD Cowen lifted their price objective on shares of UnitedHealth Group from $601.00 to $609.00 and gave the stock a “buy” rating in a research report on Friday, October 18th. Cantor Fitzgerald raised their target price on shares of UnitedHealth Group from $591.00 to $644.00 and gave the stock an “overweight” rating in a research note on Wednesday, October 16th. Stephens lowered their price target on shares of UnitedHealth Group from $632.00 to $605.00 and set an “overweight” rating on the stock in a report on Wednesday, October 16th. Finally, Royal Bank of Canada decreased their target price on UnitedHealth Group from $615.00 to $595.00 and set an “outperform” rating on the stock in a research report on Wednesday, October 16th. Four research analysts have rated the stock with a hold rating, seventeen have given a buy rating and two have issued a strong buy rating to the stock. According to data from MarketBeat, the stock has a consensus rating of “Moderate Buy” and an average price target of $615.53.
UnitedHealth Group Price Performance
UNH stock opened at $606.32 on Wednesday. The company has a 50 day simple moving average of $583.53 and a 200 day simple moving average of $554.65. The stock has a market cap of $557.98 billion, a price-to-earnings ratio of 39.50, a P/E/G ratio of 1.78 and a beta of 0.58. The company has a debt-to-equity ratio of 0.74, a current ratio of 0.91 and a quick ratio of 0.91. UnitedHealth Group Incorporated has a 1 year low of $436.38 and a 1 year high of $630.73.
UnitedHealth Group (NYSE:UNH – Get Free Report) last announced its quarterly earnings results on Tuesday, October 15th. The healthcare conglomerate reported $7.15 EPS for the quarter, beating analysts’ consensus estimates of $7.00 by $0.15. UnitedHealth Group had a return on equity of 26.37% and a net margin of 3.63%. The firm had revenue of $100.82 billion for the quarter, compared to analyst estimates of $99.14 billion. During the same period last year, the firm posted $6.56 earnings per share. The business’s revenue for the quarter was up 9.2% on a year-over-year basis. Research analysts anticipate that UnitedHealth Group Incorporated will post 27.6 EPS for the current fiscal year.
UnitedHealth Group Dividend Announcement
The business also recently announced a quarterly dividend, which will be paid on Tuesday, December 17th. Shareholders of record on Monday, December 9th will be issued a dividend of $2.10 per share. This represents a $8.40 annualized dividend and a yield of 1.39%. The ex-dividend date is Monday, December 9th. UnitedHealth Group’s payout ratio is presently 54.72%.
UnitedHealth Group Profile
UnitedHealth Group Incorporated operates as a diversified health care company in the United States. The company operates through four segments: UnitedHealthcare, Optum Health, Optum Insight, and Optum Rx. The UnitedHealthcare segment offers consumer-oriented health benefit plans and services for national employers, public sector employers, mid-sized employers, small businesses, and individuals; health care coverage, and health and well-being services to individuals age 50 and older addressing their needs; Medicaid plans, children's health insurance and health care programs; and health and dental benefits, and hospital and clinical services, as well as health care benefits products and services to state programs caring for the economically disadvantaged, medically underserved, and those without the benefit of employer-funded health care coverage.
Featured Articles
- Five stocks we like better than UnitedHealth Group
- What is a buyback in stocks? A comprehensive guide for investors
- Cerence Up 155% in 2 Days: SoundHound AI’s Fierce Competitor
- Quiet Period Expirations Explained
- Why Warren Buffett Is Selling: A Look at His Latest Market Moves
- 3 Stocks to Consider Buying in October
- Why Amazon Shares May Never Trade Below $200 Again
Receive News & Ratings for UnitedHealth Group Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for UnitedHealth Group and related companies with MarketBeat.com's FREE daily email newsletter.